237 related articles for article (PubMed ID: 28391045)
1. Luteolin inhibits colorectal cancer cell epithelial-to-mesenchymal transition by suppressing CREB1 expression revealed by comparative proteomics study.
Liu Y; Lang T; Jin B; Chen F; Zhang Y; Beuerman RW; Zhou L; Zhang Z
J Proteomics; 2017 May; 161():1-10. PubMed ID: 28391045
[TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV Induced miR-134 Expression Reduces EMT and Increases Chemotherapeutic Sensitivity by Suppressing CREB1 Signaling in Colorectal Cancer Cell Line SW-480.
Ye Q; Su L; Chen D; Zheng W; Liu Y
Cell Physiol Biochem; 2017; 43(4):1617-1626. PubMed ID: 29041002
[TBL] [Abstract][Full Text] [Related]
3. The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells.
Fortunato A
Cell Oncol (Dordr); 2017 Aug; 40(4):367-378. PubMed ID: 28593575
[TBL] [Abstract][Full Text] [Related]
4. Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression.
Lin D; Kuang G; Wan J; Zhang X; Li H; Gong X; Li H
Oncol Rep; 2017 Feb; 37(2):895-902. PubMed ID: 27959422
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of aquaporin 5-mediated epithelial-mesenchymal transition and anti-metastatic effect by natural product Cairicoside E in colorectal cancer.
Chen C; Ma T; Zhang C; Zhang H; Bai L; Kong L; Luo J
Mol Carcinog; 2017 Dec; 56(12):2692-2705. PubMed ID: 28833571
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
7. Physcion inhibits the metastatic potential of human colorectal cancer SW620 cells in vitro by suppressing the transcription factor SOX2.
Han YT; Chen XH; Gao H; Ye JL; Wang CB
Acta Pharmacol Sin; 2016 Feb; 37(2):264-75. PubMed ID: 26707141
[TBL] [Abstract][Full Text] [Related]
8. miR-598 inhibits metastasis in colorectal cancer by suppressing JAG1/Notch2 pathway stimulating EMT.
Chen J; Zhang H; Chen Y; Qiao G; Jiang W; Ni P; Liu X; Ma L
Exp Cell Res; 2017 Mar; 352(1):104-112. PubMed ID: 28161537
[TBL] [Abstract][Full Text] [Related]
9. Wnt/β-catenin pathway transactivates microRNA-150 that promotes EMT of colorectal cancer cells by suppressing CREB signaling.
Guo YH; Wang LQ; Li B; Xu H; Yang JH; Zheng LS; Yu P; Zhou AD; Zhang Y; Xie SJ; Liang ZR; Zhang CM; Zhou H; Qu LH
Oncotarget; 2016 Jul; 7(27):42513-42526. PubMed ID: 27285761
[TBL] [Abstract][Full Text] [Related]
10. Luteolin attenuates Wnt signaling via upregulation of FZD6 to suppress prostate cancer stemness revealed by comparative proteomics.
Han K; Lang T; Zhang Z; Zhang Y; Sun Y; Shen Z; Beuerman RW; Zhou L; Min D
Sci Rep; 2018 Jun; 8(1):8537. PubMed ID: 29867083
[TBL] [Abstract][Full Text] [Related]
11. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
[TBL] [Abstract][Full Text] [Related]
12. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
Lee SC; Kim OH; Lee SK; Kim SJ
Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
[TBL] [Abstract][Full Text] [Related]
13. BDE-99 (2,2',4,4',5-pentabromodiphenyl ether) triggers epithelial-mesenchymal transition in colorectal cancer cells via PI3K/Akt/Snail signaling pathway.
Wang F; Ruan XJ; Zhang HY
Tumori; 2015; 101(2):238-45. PubMed ID: 25908029
[TBL] [Abstract][Full Text] [Related]
14. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone Inhibits TGF-β1-Induced Cell Migration by Regulating the ERK and AKT Pathways in Human Colon Cancer Cells Via CYR61.
Han S; Bui NT; Ho MT; Kim YM; Cho M; Shin DB
Cancer Res Treat; 2016 Jul; 48(3):1141-53. PubMed ID: 26693911
[TBL] [Abstract][Full Text] [Related]
16. c-Met and CREB1 are involved in miR-433-mediated inhibition of the epithelial-mesenchymal transition in bladder cancer by regulating Akt/GSK-3β/Snail signaling.
Xu X; Zhu Y; Liang Z; Li S; Xu X; Wang X; Wu J; Hu Z; Meng S; Liu B; Qin J; Xie L; Zheng X
Cell Death Dis; 2016 Feb; 7(2):e2088. PubMed ID: 26844702
[TBL] [Abstract][Full Text] [Related]
17. Herbal prescription, Danggui-Sayuk-Ga-Osuyu-Senggang-Tang, inhibits TNF-α-induced epithelial-mesenchymal transition in HCT116 colorectal cancer cells.
Lee K; Cho SG; Choi YK; Choi YJ; Lee GR; Jeon CY; Ko SG
Int J Mol Med; 2018 Jan; 41(1):373-380. PubMed ID: 29115450
[TBL] [Abstract][Full Text] [Related]
18. Unbiased proteomic and transcript analyses reveal that stathmin-1 silencing inhibits colorectal cancer metastasis and sensitizes to 5-fluorouracil treatment.
Wu W; Tan XF; Tan HT; Lim TK; Chung MC
Mol Cancer Res; 2014 Dec; 12(12):1717-28. PubMed ID: 25063586
[TBL] [Abstract][Full Text] [Related]
19. CREB1 directly activates the transcription of ribonucleotide reductase small subunit M2 and promotes the aggressiveness of human colorectal cancer.
Fang Z; Lin A; Chen J; Zhang X; Liu H; Li H; Hu Y; Zhang X; Zhang J; Qiu L; Mei L; Shao J; Chen X
Oncotarget; 2016 Nov; 7(47):78055-78068. PubMed ID: 27801665
[TBL] [Abstract][Full Text] [Related]
20. Cartilage Oligomeric Matrix Protein promotes epithelial-mesenchymal transition by interacting with Transgelin in Colorectal Cancer.
Zhong W; Hou H; Liu T; Su S; Xi X; Liao Y; Xie R; Jin G; Liu X; Zhu L; Zhang H; Song X; Yang C; Sun T; Cao H; Wang B
Theranostics; 2020; 10(19):8790-8806. PubMed ID: 32754278
[No Abstract] [Full Text] [Related]
[Next] [New Search]